Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

CRT-D

CRT-D associated with major improvements among older HFrEF patients

The study's authors said CRT use among older patients represents a "major gap in knowledge." 

When infective endocarditis after TAVR is most likely to be fatal

Researchers reviewed data from more than 900 patients, sharing their research in the American Journal of Cardiology.

Thumbnail

Researchers review PCI outcomes, find little evidence of a ‘July effect’ in interventional cardiology

New trainees may not necessarily lead to a higher risk of medical errors during PCI.

Examples of CT imaging showing aortic dissections on an acute AAA response team app that was recently cleared by the FDA from Viz.AI.

FDA Roundup: AAA EVAR recommendations, key approvals in stroke care and interventional cardiology

The FDA has been busy, sharing recommendations and clearing solutions that could have a significant impact on cardiovascular care throughout the United States. 

The Edwards Lifesciences Sapien transcatheter aortic valve replacement (TAVR) device in a heart model used to show patients how the device works.

TAVR associated with lower healthcare costs than surgery

Researchers examined Medicare data from 2016 to 2018, presenting their findings in Circulation: Cardiovascular Interventions

The mitral valve seen on 3D cardiac ultrasound offers a noninvasive surgeon's view of the valve for better diagnostics and pre-planning of structural heart procedures. Example from the GE Vivid E95 FlexiLight photo-realistic 3D/4D lighting system.

Q&A: William Zoghbi breaks down the future of echocardiography

In a new interview, former ACC and ASE President William A. Zoghbi, MD, reviews some of the biggest trends in cardiac ultrasound.

Recurrent MR after TEER: Tracking data from nearly 700 MitraClip patients

The new analysis focused on both primary and secondary MR 12 months after TEER. 

Thumbnail

Abbott implantable heart failure monitor gains expanded FDA approval

An estimated 1.2 million additional patients are now candidates for the company's small CardioMEMs HF monitor. 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.